These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25048671)

  • 1. Photopheresis up-regulates CD36 on monocytes and reduces CD25(+) and CD28(+) T cell numbers.
    Bladon J; Taylor PC
    Photodiagnosis Photodyn Ther; 2005 Jun; 2(2):119-27. PubMed ID: 25048671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo.
    Bladon J; Taylor P
    J Clin Apher; 2002; 17(4):177-82. PubMed ID: 12494410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal photopheresis: a focus on apoptosis and cytokines.
    Bladon J; Taylor PC
    J Dermatol Sci; 2006 Aug; 43(2):85-94. PubMed ID: 16797926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The down-regulation of IL1alpha and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)-treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization.
    Bladon J; Taylor PC
    Transpl Int; 2006 Apr; 19(4):319-24. PubMed ID: 16573548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes.
    Bladon J; Taylor PC
    Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):293-302. PubMed ID: 16313240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photopheresis differentially regulates the expression of phosphorylated STAT-1 and STAT-5 in treated monocytes and T cells, respectively.
    Bladon J; Taylor P
    J Cutan Med Surg; 2004; 8(3):148-56. PubMed ID: 15578129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
    Bladon J; Taylor P
    Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cutaneous T cell lymphoma with extracorporeal photopheresis induces Fas-ligand expression on treated T cells, but does not suppress the expression of co-stimulatory molecules on monocytes.
    Bladon J; Taylor PC
    J Photochem Photobiol B; 2003 Feb; 69(2):129-38. PubMed ID: 12633985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease.
    Di Renzo M; Rubegni P; Pasqui AL; Pompella G; De Aloe G; Sbano P; Cuccia A; Castagnini C; Auteri A; Laghi Pasini F; Fimiani M
    Br J Dermatol; 2005 Jul; 153(1):59-65. PubMed ID: 16029327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis.
    George JF; Gooden CW; Guo L; Kirklin JK
    J Heart Lung Transplant; 2008 Jun; 27(6):616-22. PubMed ID: 18503960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients.
    Bladon J; Taylor PC
    Br J Haematol; 1999 Dec; 107(4):707-11. PubMed ID: 10606873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of action of extracorporeal photochemotherapy.
    Heshmati F
    Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease.
    Spisek R; Gasova Z; Bartunkova J
    Transfusion; 2006 Jan; 46(1):55-65. PubMed ID: 16398731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family.
    Di Renzo M; Rubegni P; Sbano P; Cuccia A; Castagnini C; Pompella G; Pasqui AL; Capecchi PL; Auteri A; Laghi Pasini F; Fimiani M
    Arch Dermatol Res; 2003 Sep; 295(5):175-82. PubMed ID: 12883827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
    Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal photopheresis: from solid organs to face transplantation.
    Hivelin M; Siemionow M; Grimbert P; Lantieri L
    Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes.
    Bladon J; Taylor PC
    Br J Dermatol; 2002 Jan; 146(1):59-68. PubMed ID: 11841367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction.
    Bladon J; Taylor PC
    Transplant Proc; 2003 Jun; 35(4):1328-32. PubMed ID: 12826151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
    Atta M; Papanicolaou N; Tsirigotis P
    Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.